HomeENVB • NASDAQ
add
Enveric Biosciences Inc
Previous close
$0.94
Day range
$0.90 - $0.95
Year range
$0.65 - $6.98
Market cap
6.67M USD
Avg Volume
2.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.84M | -40.91% |
Net income | -3.44M | 60.41% |
Net profit margin | — | — |
Earnings per share | -1.06 | 44.40% |
EBITDA | -2.75M | 41.62% |
Effective tax rate | -0.65% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.29M | -87.09% |
Total assets | 4.30M | -78.01% |
Total liabilities | 2.34M | -41.35% |
Total equity | 1.96M | — |
Shares outstanding | 7.29M | — |
Price to book | 1.32 | — |
Return on assets | -129.93% | — |
Return on capital | -323.02% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.44M | 60.41% |
Cash from operations | -1.75M | 49.42% |
Cash from investing | -38.00 | 99.39% |
Cash from financing | -186.08K | -18,608,300.00% |
Net change in cash | -1.98M | 43.10% |
Free cash flow | -2.90M | -397.04% |
About
Founded
1994
Headquarters
Website
Employees
7